OncLive® On Air cover image

S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE

OncLive® On Air

00:00

PEComa and mTOR-Targeted Therapy

Sam notes PEComa rarity, TSC1/2 mutations, and nab-sirolimus approval for this uterine-associated tumor.

Play episode from 11:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app